Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2024

23-11-2023 | Global Health Services Research

Interventions for Concerning Patient-Reported Outcomes in Routine Cancer Care: A Systematic Review

Authors: Gianluca Sampieri, MD, MSc, Huaqi Li, MPH, Philopateer Ataalla, BScH, Kaitlyn Merriman, MLIS, Christopher W. Noel, MD, PhD, Julie Hallet, MD, MSc, FRCSC, Natalie Coburn, MD, MPH, Irene Karam, MD, Martin Smoragiewicz, MD, CM, PhD, FRCP, Brian Wong, MD, FRCPC, Rui Fu, PhD, Antoine Eskander, MD, MSc, FRCSC

Published in: Annals of Surgical Oncology | Issue 2/2024

Login to get access

Abstract

Importance

Collecting patient-reported outcomes (PROs) in routine cancer care improves patient–clinician communication, decision making, and overall patient satisfaction. Recommendations exist regarding standardized ways to collect, store, and interpret PRO data. However, evidence on incorporating PROs into cancer process of care, especially the type of HIs that are warranted after observing a concerning PRO and the effectiveness of these HIs are lacking.

Objective

This study summarizes HIs triggered after PRO completion and their effectiveness in improving patient outcomes for adults being treated for cancer types that are resource intensive and associated with high symptom burden [i.e., gastrointestinal (GI), lung, and head and neck cancer (HNC)]. Secondary outcomes included factors associated with poor implementation of PROs.

Evidence Review

A literature search of peer-reviewed publications on MEDLINE, CINAHL Plus, APA PsycInfo, Scopus, and Cochrane was conducted following PRISMA guidelines from 1 January 2012, to 31 July 2022. Trial and real-world studies describing HIs after PRO completion for adult patients being treated for GI, lung, and HNC were included. Sixteen studies involving 144,496 patients were included. The Joanna Briggs Institute critical appraisal checklist was used to assess risk of bias.

Findings

Of the 16 included studies, 5 included patients with HNC. Commonly used PRO measurement tools were the PRO-CTCAE and ESAS. Only three studies reported specific HIs delivered in response to concerning PROs and measured their effectiveness on patient outcomes. In all three studies, these HIs significantly improved cancer-related care. The most common HIs undertaken in response to concerning PROs were referrals to other specialists/allied healthcare professionals, medication changes, or self-management advice. Provider-related barriers to PRO measurement and delivery included the overwhelming number of alerts, the time required to address each PRO and the unclear role of healthcare providers in response to these alerts. Patient-related barriers included lower digital literacy and socioeconomic status, older age, rural living, and patients suffering from GI and HNC.

Conclusions and Relevance

This review highlights that PRO-triggered HIs are heterogenous and can improve patient quality of life. Further studies are necessary to determine the types of interventions with the greatest impact on patient care and outcomes.
Appendix
Available only for authorised users
Literature
2.
go back to reference Barbera L, Lee F, Sutradhar R. Use of patient-reported outcomes in regional cancer centres over time: a retrospective study. CMAJ Open. 2019;7(1):E101–8.PubMedPubMedCentral Barbera L, Lee F, Sutradhar R. Use of patient-reported outcomes in regional cancer centres over time: a retrospective study. CMAJ Open. 2019;7(1):E101–8.PubMedPubMedCentral
3.
go back to reference Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book. 2018;38:122–34.PubMed Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book. 2018;38:122–34.PubMed
4.
go back to reference Jensen RE, Snyder CF, Abernethy AP, et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. JOP. 2014;10(4):e215–22.PubMed Jensen RE, Snyder CF, Abernethy AP, et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. JOP. 2014;10(4):e215–22.PubMed
5.
go back to reference Kotronoulas G, Kearney N, Maguire R, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. JCO. 2014;32(14):1480–501. Kotronoulas G, Kearney N, Maguire R, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. JCO. 2014;32(14):1480–501.
6.
go back to reference Howell D, Molloy S, Wilkinson K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015;26(9):1846–58.PubMed Howell D, Molloy S, Wilkinson K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015;26(9):1846–58.PubMed
7.
go back to reference Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13(1):211.PubMedPubMedCentral Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13(1):211.PubMedPubMedCentral
8.
go back to reference Efficace F, Collins GS, Cottone F, et al. Patient-reported outcomes as independent prognostic factors for survival in oncology: systematic review and meta-analysis. Value Health. 2021;24(2):250–67.PubMed Efficace F, Collins GS, Cottone F, et al. Patient-reported outcomes as independent prognostic factors for survival in oncology: systematic review and meta-analysis. Value Health. 2021;24(2):250–67.PubMed
9.
go back to reference LeBlanc TW, Abernethy AP. Patient-reported outcomes in cancer care—hearing the patient voice at greater volume. Nat Rev Clin Oncol. 2017;14(12):763–72.PubMed LeBlanc TW, Abernethy AP. Patient-reported outcomes in cancer care—hearing the patient voice at greater volume. Nat Rev Clin Oncol. 2017;14(12):763–72.PubMed
10.
go back to reference Warsame R, D’Souza A. Patient reported outcomes have arrived: a practical overview for clinicians in using patient reported outcomes in oncology. Mayo Clin Proc. 2019;94(11):2291–301.PubMed Warsame R, D’Souza A. Patient reported outcomes have arrived: a practical overview for clinicians in using patient reported outcomes in oncology. Mayo Clin Proc. 2019;94(11):2291–301.PubMed
11.
go back to reference Anatchkova M, Donelson SM, Skalicky AM, et al. Exploring the implementation of patient-reported outcome measures in cancer care: need for more real-world evidence results in the peer reviewed literature. J Patient Rep Outcomes. 2018;2(1):64.PubMedPubMedCentral Anatchkova M, Donelson SM, Skalicky AM, et al. Exploring the implementation of patient-reported outcome measures in cancer care: need for more real-world evidence results in the peer reviewed literature. J Patient Rep Outcomes. 2018;2(1):64.PubMedPubMedCentral
12.
go back to reference Silveira A, Sequeira T, Gonçalves J, Lopes Ferreira P. Patient reported outcomes in oncology: changing perspectives—a systematic review. Health Qual Life Outcomes. 2022;20(1):82.PubMedPubMedCentral Silveira A, Sequeira T, Gonçalves J, Lopes Ferreira P. Patient reported outcomes in oncology: changing perspectives—a systematic review. Health Qual Life Outcomes. 2022;20(1):82.PubMedPubMedCentral
15.
go back to reference Montgomery N, Howell D, Ismail Z, et al. Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: The Cancer Care Ontario approach. J Patient Rep Outcomes. 2020;4(101):1–9. Montgomery N, Howell D, Ismail Z, et al. Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: The Cancer Care Ontario approach. J Patient Rep Outcomes. 2020;4(101):1–9.
16.
go back to reference Di Maio M, Basch E, Denis F, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann Oncol. 2022;33(9):878–92.PubMed Di Maio M, Basch E, Denis F, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann Oncol. 2022;33(9):878–92.PubMed
17.
go back to reference Basch E, Schrag D, Henson S, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: A randomized clinical trial. JAMA. 2022;327(24):2413.PubMedPubMedCentral Basch E, Schrag D, Henson S, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: A randomized clinical trial. JAMA. 2022;327(24):2413.PubMedPubMedCentral
18.
go back to reference Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.PubMed Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.PubMed
19.
go back to reference Van Cleave JH, Fu MR, Bennett AV, et al. The usefulness of the Electronic Patient Visit Assessment (ePVA)© as a clinical support tool for real-time interventions in head and neck cancer. mHealth. 2021;7:7.PubMedPubMedCentral Van Cleave JH, Fu MR, Bennett AV, et al. The usefulness of the Electronic Patient Visit Assessment (ePVA)© as a clinical support tool for real-time interventions in head and neck cancer. mHealth. 2021;7:7.PubMedPubMedCentral
20.
go back to reference Nipp RD, Horick NK, Qian CL, et al. Effect of a symptom monitoring intervention for patients hospitalized with advanced cancer: a randomized clinical trial. JAMA Oncology. 2022;8(4):571–8.PubMedPubMedCentral Nipp RD, Horick NK, Qian CL, et al. Effect of a symptom monitoring intervention for patients hospitalized with advanced cancer: a randomized clinical trial. JAMA Oncology. 2022;8(4):571–8.PubMedPubMedCentral
21.
go back to reference Wujcik D, Dudley WN, Dudley M, et al. Electronic patient symptom management program to support patients receiving cancer treatment at home during the covid-19 pandemic. Value Health. 2022;25(6):931–6.PubMedPubMedCentral Wujcik D, Dudley WN, Dudley M, et al. Electronic patient symptom management program to support patients receiving cancer treatment at home during the covid-19 pandemic. Value Health. 2022;25(6):931–6.PubMedPubMedCentral
22.
go back to reference Bubis LD, Davis L, Mahar A, et al. Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes. J Clin Oncol. 2018;36(11):1103–11.PubMed Bubis LD, Davis L, Mahar A, et al. Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes. J Clin Oncol. 2018;36(11):1103–11.PubMed
23.
go back to reference Noel CW, Sutradhar R, Zhao H, et al. Patient-reported symptom burden as a predictor of emergency department use and unplanned hospitalization in head and neck cancer: A longitudinal population-based study. J Clin Oncol. 2021;39(6):675–84.PubMed Noel CW, Sutradhar R, Zhao H, et al. Patient-reported symptom burden as a predictor of emergency department use and unplanned hospitalization in head and neck cancer: A longitudinal population-based study. J Clin Oncol. 2021;39(6):675–84.PubMed
24.
go back to reference Hallet J, Sutradhar R, Isenberg-Grzeda E, et al. Association of patient-reported outcomes with subsequent nonfatal self-injury after a new cancer diagnosis. JAMA Oncol. 2022;8(5):e220203.PubMedPubMedCentral Hallet J, Sutradhar R, Isenberg-Grzeda E, et al. Association of patient-reported outcomes with subsequent nonfatal self-injury after a new cancer diagnosis. JAMA Oncol. 2022;8(5):e220203.PubMedPubMedCentral
25.
go back to reference Noel CW, Du YJ, Baran E, et al. Enhancing outpatient symptom management in patients with head and neck cancer: a qualitative analysis. JAMA Otolaryngol Head Neck Surg. 2022;148(4):333–41.PubMedPubMedCentral Noel CW, Du YJ, Baran E, et al. Enhancing outpatient symptom management in patients with head and neck cancer: a qualitative analysis. JAMA Otolaryngol Head Neck Surg. 2022;148(4):333–41.PubMedPubMedCentral
26.
go back to reference Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.PubMedPubMedCentral Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.PubMedPubMedCentral
27.
go back to reference Bouazza YB, Chiairi I, El Kharbouchi O, et al. Patient-reported outcome measures (PROMs) in the management of lung cancer: a systematic review. Lung Cancer. 2017;113:140–51.PubMed Bouazza YB, Chiairi I, El Kharbouchi O, et al. Patient-reported outcome measures (PROMs) in the management of lung cancer: a systematic review. Lung Cancer. 2017;113:140–51.PubMed
28.
go back to reference Noel CW, Sutradhar R, Chan WC, et al. Gaps in depression symptom management for patients with head and neck cancer. Laryngoscope. 2023;133:2638–46.PubMed Noel CW, Sutradhar R, Chan WC, et al. Gaps in depression symptom management for patients with head and neck cancer. Laryngoscope. 2023;133:2638–46.PubMed
29.
go back to reference Munn Z, Barker TH, Sandeep M, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127–33.PubMed Munn Z, Barker TH, Sandeep M, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127–33.PubMed
30.
go back to reference Munn Z, Sandeep M, Dagmara R, Karolina L. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123.PubMedPubMedCentral Munn Z, Sandeep M, Dagmara R, Karolina L. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123.PubMedPubMedCentral
31.
go back to reference Akerley R, Karl C. Call back: using the phone to promote adherence to oral antineoplastic agents. J Oncol Navig Surviv. 2021;12(6):173–6. Akerley R, Karl C. Call back: using the phone to promote adherence to oral antineoplastic agents. J Oncol Navig Surviv. 2021;12(6):173–6.
32.
go back to reference Chhabria K, Kansara S, Badr H, et al. Gastrostomy utilization by oropharyngeal cancer patients is partially driven by swallowing function. Laryngoscope. 2020;130(9):2153–9.PubMed Chhabria K, Kansara S, Badr H, et al. Gastrostomy utilization by oropharyngeal cancer patients is partially driven by swallowing function. Laryngoscope. 2020;130(9):2153–9.PubMed
33.
go back to reference Cooley ME, Mazzola E, Xiong N, et al. clinical decision support for symptom management in lung cancer patients: A group RCT. J Pain Symptom Manag. 2022;63(4):572–80. Cooley ME, Mazzola E, Xiong N, et al. clinical decision support for symptom management in lung cancer patients: A group RCT. J Pain Symptom Manag. 2022;63(4):572–80.
34.
go back to reference Dai W, Feng W, Zhang Y, et al. Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: a multicenter randomized controlled trial. J Clin Oncol. 2022;40(9):988–96.PubMedPubMedCentral Dai W, Feng W, Zhang Y, et al. Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: a multicenter randomized controlled trial. J Clin Oncol. 2022;40(9):988–96.PubMedPubMedCentral
35.
go back to reference Denis F, Lethrosne C, Pourel N, et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst. 2017;109(9):djx029. Denis F, Lethrosne C, Pourel N, et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst. 2017;109(9):djx029.
36.
go back to reference Doolin JW, Berry JL, Forbath NS, et al. Implementing electronic patient-reported outcomes for patients with new oral chemotherapy prescriptions at an academic site and a community site. JCO Clin Cancer Inform. 2021;5:631–40.PubMed Doolin JW, Berry JL, Forbath NS, et al. Implementing electronic patient-reported outcomes for patients with new oral chemotherapy prescriptions at an academic site and a community site. JCO Clin Cancer Inform. 2021;5:631–40.PubMed
37.
go back to reference Geerse OP, Hoekstra-Weebers JE, Stokroos MH, Burgerhof JG, Groen HJ, Kerstjens HA, Hiltermann TJ. Structural distress screening and supportive care for patients with lung cancer on systemic therapy: a randomised controlled trial. Eur J Cancer. 2017;72:37–45.PubMed Geerse OP, Hoekstra-Weebers JE, Stokroos MH, Burgerhof JG, Groen HJ, Kerstjens HA, Hiltermann TJ. Structural distress screening and supportive care for patients with lung cancer on systemic therapy: a randomised controlled trial. Eur J Cancer. 2017;72:37–45.PubMed
38.
go back to reference Girgis A, Bamgboje-Ayodele A, Rincones O, et al. Stepping into the real world: A mixed-methods evaluation of the implementation of electronic patient reported outcomes in routine lung cancer care. J Patient Rep Outcomes. 2022;6(1):70.PubMedPubMedCentral Girgis A, Bamgboje-Ayodele A, Rincones O, et al. Stepping into the real world: A mixed-methods evaluation of the implementation of electronic patient reported outcomes in routine lung cancer care. J Patient Rep Outcomes. 2022;6(1):70.PubMedPubMedCentral
39.
go back to reference Hallet J, Davis LE, Isenberg-Grzeda E, et al. Gaps in the management of depression symptoms following cancer diagnosis: a population-based analysis of prospective patient-reported outcomes. Oncol. 2020;25(7):e1098–108. Hallet J, Davis LE, Isenberg-Grzeda E, et al. Gaps in the management of depression symptoms following cancer diagnosis: a population-based analysis of prospective patient-reported outcomes. Oncol. 2020;25(7):e1098–108.
40.
go back to reference Henry M, Frenkiel S, Chartier G, et al. Thyroid cancer patients receiving an interdisciplinary team-based care approach (ITCA-ThyCa) appear to display better outcomes: program evaluation results indicating a need for further integrated care and support. Psychooncology. 2018;27(3):937–45.PubMed Henry M, Frenkiel S, Chartier G, et al. Thyroid cancer patients receiving an interdisciplinary team-based care approach (ITCA-ThyCa) appear to display better outcomes: program evaluation results indicating a need for further integrated care and support. Psychooncology. 2018;27(3):937–45.PubMed
41.
go back to reference Kuo JC, Graham DM, Salvarrey A, et al. A randomized trial of the electronic lung cancer symptom scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer. Curr Oncol. 2020;27(2):e156–62.PubMedPubMedCentral Kuo JC, Graham DM, Salvarrey A, et al. A randomized trial of the electronic lung cancer symptom scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer. Curr Oncol. 2020;27(2):e156–62.PubMedPubMedCentral
42.
go back to reference Mody GN, Stover AM, Wang M, et al. Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: a nested cohort within the PRO-TECT pragmatic trial (AFT-39). Lung Cancer. 2021;162:1–8.PubMed Mody GN, Stover AM, Wang M, et al. Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: a nested cohort within the PRO-TECT pragmatic trial (AFT-39). Lung Cancer. 2021;162:1–8.PubMed
43.
go back to reference Rhondali W, Yennurajalingam S, Ferrer J, et al. Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients. Support Care Cancer. 2014;22(4):871–9.PubMed Rhondali W, Yennurajalingam S, Ferrer J, et al. Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients. Support Care Cancer. 2014;22(4):871–9.PubMed
44.
go back to reference Sun V, Dumitra S, Ruel N, et al. Wireless monitoring program of patient-centered outcomes and recovery before and after major abdominal cancer surgery. JAMA Surg. 2017;152(9):852–9.PubMedPubMedCentral Sun V, Dumitra S, Ruel N, et al. Wireless monitoring program of patient-centered outcomes and recovery before and after major abdominal cancer surgery. JAMA Surg. 2017;152(9):852–9.PubMedPubMedCentral
45.
go back to reference Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–8.PubMedPubMedCentral Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–8.PubMedPubMedCentral
46.
go back to reference Koay K, Schofield P, Gough K, et al. Suboptimal health literacy in patients with lung cancer or head and neck cancer. Support Care Cancer. 2013;21(8):2237–45.PubMed Koay K, Schofield P, Gough K, et al. Suboptimal health literacy in patients with lung cancer or head and neck cancer. Support Care Cancer. 2013;21(8):2237–45.PubMed
47.
go back to reference Beitler JJ, Chen AY, Jacobson K, et al. Health literacy and health care in an inner-city, total laryngectomy population. Am J Otolaryngol. 2010;31(1):29–31.PubMed Beitler JJ, Chen AY, Jacobson K, et al. Health literacy and health care in an inner-city, total laryngectomy population. Am J Otolaryngol. 2010;31(1):29–31.PubMed
Metadata
Title
Interventions for Concerning Patient-Reported Outcomes in Routine Cancer Care: A Systematic Review
Authors
Gianluca Sampieri, MD, MSc
Huaqi Li, MPH
Philopateer Ataalla, BScH
Kaitlyn Merriman, MLIS
Christopher W. Noel, MD, PhD
Julie Hallet, MD, MSc, FRCSC
Natalie Coburn, MD, MPH
Irene Karam, MD
Martin Smoragiewicz, MD, CM, PhD, FRCP
Brian Wong, MD, FRCPC
Rui Fu, PhD
Antoine Eskander, MD, MSc, FRCSC
Publication date
23-11-2023
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-14576-z

Other articles of this Issue 2/2024

Annals of Surgical Oncology 2/2024 Go to the issue